The increase in price target from $655 to $680 by Morgan Stanley, along with the maintained Overweight rating, indicates a strong positive sentiment towards Thermo Fisher Scientific's future performance. This is likely to have a positive short-term impact on the stock price as investors may view this as a sign of confidence from a reputable financial institution.